BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Quero JC, Hartmann IJ, Meulstee J, Hop WC, Schalm SW. The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis. Hepatology 1996;24:556-60. [DOI: 10.1002/hep.510240316] [Cited by in Crossref: 131] [Cited by in F6Publishing: 127] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Lozeva V, Valjakka A, Anttila E, Macdonald E, Hippeläinen M, Tuomisto L. Brain histamine levels and neocortical slow-wave activity in rats with portacaval anastomosis: Brain Histamine Levels and Neocortical Slow-Wave Activity in Rats With Portacaval Anastomosis. Hepatology 1999;29:340-6. [DOI: 10.1002/hep.510290204] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
2 Pascoli D, Guérit J, Montagnese S, de Tourtchaninoff M, Minelli T, Pellegrini A, Del Piccolo F, Gatta A, Amodio P. Analysis of EEG tracings in frequency and time domain in hepatic encephalopathy. Computer Methods and Programs in Biomedicine 2006;81:203-12. [DOI: 10.1016/j.cmpb.2005.10.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
3 Amodio P. Health related quality of life and minimal hepatic encephalopathy. It is time to insert ‘quality’ in health care. Journal of Gastroenterology and Hepatology 2009;24:329-30. [DOI: 10.1111/j.1440-1746.2009.05781.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
4 Dhiman RK, Chawla YK. Minimal hepatic encephalopathy. Indian J Gastroenterol. 2009;28:5-16. [PMID: 19529896 DOI: 10.1007/s12664-009-0003-6] [Cited by in Crossref: 63] [Cited by in F6Publishing: 52] [Article Influence: 4.8] [Reference Citation Analysis]
5 Bayat M, Khalili A, Bayat G, Akbari S, Yousefi Nejad A, Borhani Haghighi A, Haghani M. Effects of platelet-rich plasma on the memory impairment, apoptosis, and hippocampal synaptic plasticity in a rat model of hepatic encephalopathy. Brain Behav 2021;:e32447. [PMID: 34855284 DOI: 10.1002/brb3.2447] [Reference Citation Analysis]
6 Heidari R, Jamshidzadeh A, Ommati MM, Rashidi E, Khodaei F, Sadeghi A, Hosseini A, Niknahad H. Ammonia-induced mitochondrial impairment is intensified by manganese co-exposure: relevance to the management of subclinical hepatic encephalopathy and cirrhosis-associated brain injury. Clin Exp Hepatol 2019;5:109-17. [PMID: 31501786 DOI: 10.5114/ceh.2019.85071] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
7 Häussinger D, Córdoba J, Kircheis G, Vilstrup H, Fleig WE, Jones EA, Schleiss F, Blei AT. Definition and assessment of low-grade hepatic encephalopathy. In: Häussinger D, Kircheis G, Schliess F, editors. Hepatic Encephalopathy and Nitrogen Metabolism. Dordrecht: Springer Netherlands; 2006. pp. 423-32. [DOI: 10.1007/1-4020-4456-9_32] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
8 Weissenborn K, Ennen JC, Schomerus H, Rückert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol. 2001;34:768-773. [PMID: 11434627 DOI: 10.1016/s0168-8278(01)00026-5] [Cited by in Crossref: 491] [Cited by in F6Publishing: 194] [Article Influence: 23.4] [Reference Citation Analysis]
9 Riggio O, Ridola L. Emerging drugs for hepatic encephalopathy. Expert Opin Emerg Drugs 2009;14:537-49. [PMID: 19552607 DOI: 10.1517/14728210903055067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
10 Riggio O, Ridola L, Pasquale C. Hepatic encephalopathy therapy: An overview. World J Gastrointest Pharmacol Ther 2010; 1(2): 54-63 [PMID: 21577297 DOI: 10.4292/wjgpt.v1.i2.54] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
11 Schiff S, Vallesi A, Mapelli D, Orsato R, Pellegrini A, Umiltà C, Gatta A, Amodio P. Impairment of Response Inhibition Precedes Motor Alteration in the Early Stage of Liver Cirrhosis: A Behavioral and Electrophysiological Study. Metab Brain Dis 2005;20:381-92. [DOI: 10.1007/s11011-005-7922-4] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 2.9] [Reference Citation Analysis]
12 Watanabe A. Cerebral changes in hepatic encephalopathy. J Gastroenterol Hepatol 1998;13:752-60. [PMID: 9715431 DOI: 10.1111/j.1440-1746.1998.tb00728.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
13 Kircheis G, Fleig WE, Görtelmeyer R, Grafe S, Häussinger D. Assessment of low-grade hepatic encephalopathy: a critical analysis. J Hepatol 2007;47:642-50. [PMID: 17869373 DOI: 10.1016/j.jhep.2007.05.019] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 3.4] [Reference Citation Analysis]
14 Olesen SS, Gram M, Jackson CD, Halliday E, Sandberg TH, Drewes AM, Morgan MY. Electroencephalogram variability in patients with cirrhosis associates with the presence and severity of hepatic encephalopathy. J Hepatol 2016;65:517-23. [PMID: 27184531 DOI: 10.1016/j.jhep.2016.05.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
15 Saxena N, Bhatia M, Joshi YK, Garg PK, Dwivedi SN, Tandon RK. Electrophysiological and neuropsychological tests for the diagnosis of subclinical hepatic encephalopathy and prediction of overt encephalopathy. Liver. 2002;22:190-197. [PMID: 12100568 DOI: 10.1034/j.1600-0676.2002.01431.x] [Cited by in Crossref: 87] [Cited by in F6Publishing: 73] [Article Influence: 4.6] [Reference Citation Analysis]
16 McAndrews MP, Farcnik K, Carlen P, Damyanovich A, Mrkonjic M, Jones S, Heathcote EJ. Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors. Hepatology. 2005;41:801-808. [PMID: 15793853 DOI: 10.1002/hep.20635] [Cited by in Crossref: 149] [Cited by in F6Publishing: 133] [Article Influence: 8.8] [Reference Citation Analysis]
17 Ong JP, Mullen KD. Hepatic encephalopathy. Eur J Gastroenterol Hepatol. 2001;13:325-334. [PMID: 11338058 DOI: 10.1097/00042737-200104000-00005] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
18 Amodio P, Orsato R, Marchetti P, Schiff S, Poci C, Angeli P, Gatta A, Sparacino G, Toffolo G. Electroencephalographic analysis for the assessment of hepatic encephalopathy: Comparison of non-parametric and parametric spectral estimation techniques. Neurophysiologie Clinique/Clinical Neurophysiology 2009;39:107-15. [DOI: 10.1016/j.neucli.2009.02.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
19 Huang E, Esrailian E, Spiegel BM. The cost-effectiveness and budget impact of competing therapies in hepatic encephalopathy - a decision analysis. Aliment Pharmacol Ther. 2007;26:1147-1161. [PMID: 17894657 DOI: 10.1111/j.1365-2036.2007.03464.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
20 Nikaina I, Pastaka C, Zachou K, Dalekos GN, Gourgoulianis K. Sleep apnoea syndrome and early stage cirrhosis: a pilot study. Eur J Gastroenterol Hepatol 2006;18:31-5. [PMID: 16357616 DOI: 10.1097/00042737-200601000-00006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
21 Douglass A, Al Mardini H, Record C. Amino acid challenge in patients with cirrhosis: a model for the assessment of treatments for hepatic encephalopathy. J Hepatol. 2001;34:658-664. [PMID: 11434611 DOI: 10.1016/s0168-8278(01)00004-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
22 Gad YZ, Zaher AA, Moussa NH, El-desoky AE, Al-Adarosy HA. Screening for minimal hepatic encephalopathy in asymptomatic drivers with liver cirrhosis. Arab J Gastroenterol. 2011;12:58-61. [PMID: 21684474 DOI: 10.1016/j.ajg.2011.04.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
23 Guérit JM, Amodio P, Hafner H, Litscher G, Van Huffelen AC. Neuromonitoring in the operating room and intensive care unit: an update. Suppl Clin Neurophysiol 2000;53:61-71. [PMID: 12740978 DOI: 10.1016/s1567-424x(09)70139-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
24 Forton DM, Thomas HC, Taylor-robinson SD. Quality of life and cognitive function in chronic hepatitis C – what to measure? Journal of Hepatology 2003;39:272-4. [DOI: 10.1016/s0168-8278(03)00268-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Sharma P, Sharma BC, Puri V, Sarin SK. Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy. J Hepatol. 2007;47:67-73. [PMID: 17459511 DOI: 10.1016/j.jhep.2007.02.022] [Cited by in Crossref: 123] [Cited by in F6Publishing: 106] [Article Influence: 8.2] [Reference Citation Analysis]
26 Nolte W, Wiltfang J, Schindler C, Münke H, Unterberg K, Zumhasch U, Figulla HR, Werner G, Hartmann H, Ramadori G. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations. Hepatology. 1998;28:1215-1225. [PMID: 9794904 DOI: 10.1002/hep.510280508] [Cited by in Crossref: 100] [Cited by in F6Publishing: 98] [Article Influence: 4.2] [Reference Citation Analysis]
27 Als-nielsen B, Kjaergard L, Gluud C. Nonabsorbable disaccharides for hepatic encephalopathy. The Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd003044] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
28 Groeneweg M, Moerland W, Quero JC, Hop WC, Krabbe PF, Schalm SW. Screening of subclinical hepatic encephalopathy. J Hepatol. 2000;32:748-753. [PMID: 10845661 DOI: 10.1016/s0168-8278(00)80243-3] [Cited by in Crossref: 127] [Cited by in F6Publishing: 42] [Article Influence: 5.8] [Reference Citation Analysis]
29 Savlan I, Liakina V, Valantinas J. Concise review of current concepts on nomenclature and pathophysiology of hepatic encephalopathy. Medicina (Kaunas). 2014;50:75-81. [PMID: 25172600 DOI: 10.1016/j.medici.2014.06.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
30 Hillebrand DJ, Kojouri K, Cao S, Runyon BA, Ojogho O, Concepcion W. Small-diameter portacaval H-graft shunt: a paradigm shift back to surgical shunting in the management of variceal bleeding in patients with preserved liver function. Liver Transpl 2000;6:459-65. [PMID: 10915169 DOI: 10.1053/jlts.2000.6141] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
31 Souto PA, Marcotegui AR, Orbea L, Skerl J, Perazzo JC. Hepatic encephalopathy: Ever closer to its big bang. World J Gastroenterol 2016; 22(42): 9251-9256 [PMID: 27895414 DOI: 10.3748/wjg.v22.i42.9251] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
32 Giger-Mateeva VI, Riemslag FC, Reits D, Liberov B, Jones EA, Spekreijse H. Visual event-related potentials in cirrhotic patients without overt encephalopathy. Metab Brain Dis 2000;15:179-91. [PMID: 11206587 DOI: 10.1007/BF02674527] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
33 Amodio P, Marchetti P, Del Piccolo F, de Tourtchaninoff M, Varghese P, Zuliani C, Campo G, Gatta A, Guérit J. Spectral versus visual EEG analysis in mild hepatic encephalopathy. Clinical Neurophysiology 1999;110:1334-44. [DOI: 10.1016/s1388-2457(99)00076-0] [Cited by in Crossref: 130] [Cited by in F6Publishing: 28] [Article Influence: 5.7] [Reference Citation Analysis]
34 Chakrabarti P, Zullo A, Hassan C, Pandit A, Chowdhury A, Santra A, Hazra B, Morini S, Roy T. Helicobacter pylori, Gastric Juice, and Arterial Ammonia Levels in Patients with Cirrhosis: . Journal of Clinical Gastroenterology 2002;34:578-81. [DOI: 10.1097/00004836-200205000-00020] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
35 Wein C, Koch H, Popp B, Oehler G, Schauder P. Minimal hepatic encephalopathy impairs fitness to drive. Hepatology 2004;39:739-45. [DOI: 10.1002/hep.20095] [Cited by in Crossref: 215] [Cited by in F6Publishing: 181] [Article Influence: 11.9] [Reference Citation Analysis]
36 Jover R, Compañy L, Gutiérrez A, Zapater P, Pérez-serra J, Girona E, Aparicio JR, Pérez-mateo M. Minimal Hepatic Encephalopathy and Extrapyramidal Signs in Patients With Cirrhosis. American Journal of Gastroenterology 2003;98:1599-604. [DOI: 10.1111/j.1572-0241.2003.07528.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
37 Zhang Y, Feng Y, Cao B, Tian Q. The effect of small intestinal bacterial overgrowth on minimal hepatic encephalopathy in patients with cirrhosis. Arch Med Sci. 2016;12:592-596. [PMID: 27279853 DOI: 10.5114/aoms.2015.55675] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
38 Hourmand-ollivier I, Dao T. Subclinical Encephalopathy After Conscious Sedation With Midazolam in Cirrhotic Patients? American Journal of Gastroenterology 2003;98:1450-1. [DOI: 10.1111/j.1572-0241.2003.07505.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
39 Moriwaki H, Shiraki M, Iwasa J, Terakura Y. Hepatic encephalopathy as a complication of liver cirrhosis: an Asian perspective. J Gastroenterol Hepatol. 2010;25:858-863. [PMID: 20546438 DOI: 10.1111/j.1440-1746.2010.06242.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
40 Yoo HY, Edwin D, Thuluvath PJ. Relationship of The Model for End-Stage Liver Disease (Meld) Scale To Hepatic Encephalopathy, As Defined by Electroencephalography and Neuropsychometric Testing, and Ascites. American Journal of Gastroenterology 2003;98:1395-9. [DOI: 10.1111/j.1572-0241.2003.07466.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 3.3] [Reference Citation Analysis]
41 Frank Y, Ashwal S. Neurologic Disorders Associated with Gastrointestinal Diseases and Nutritional Deficiencies. Swaiman's Pediatric Neurology. Elsevier; 2012. pp. 1821-66. [DOI: 10.1016/b978-1-4377-0435-8.00079-2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
42 Romero-Gómez M, Grande L, Camacho I, Benitez S, Irles JA, Castro M. Altered response to oral glutamine challenge as prognostic factor for overt episodes in patients with minimal hepatic encephalopathy. J Hepatol 2002;37:781-7. [PMID: 12445419 DOI: 10.1016/s0168-8278(02)00330-6] [Cited by in Crossref: 51] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
43 Riggio O, Ridola L, Pasquale C, Pentassuglio I, Nardelli S, Moscucci F, Merli M, Montagnese S, Amodio P, Merkel C. A simplified psychometric evaluation for the diagnosis of minimal hepatic encephalopathy. Clin Gastroenterol Hepatol. 2011;9:613-616.e1. [PMID: 21440091 DOI: 10.1016/j.cgh.2011.03.017] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
44 Hartmann IJ, Groeneweg M, Quero JC, Beijeman SJ, de Man RA, Hop WC, Schalm SW. The prognostic significance of subclinical hepatic encephalopathy. Am J Gastroenterol. 2000;95:2029-2034. [PMID: 10950053 DOI: 10.1111/j.1572-0241.2000.02265.x] [Cited by in Crossref: 147] [Cited by in F6Publishing: 134] [Article Influence: 6.7] [Reference Citation Analysis]
45 Michitaka K, Tokumoto Y, Uesugi K, Kisaka Y, Hirooka M, Konishi I, Mashiba T, Abe M, Hiasa Y, Matsuura B, Horiike N, Shoda T, Onji M. Neuropsychiatric dysfunction in patients with chronic hepatitis and liver cirrhosis. Hepatology Research 2008;38:1069-75. [DOI: 10.1111/j.1872-034x.2008.00374.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
46 Bahn E, Wiltfang J, Nolte W, Ramadori G, Steinhoff B, Rüther E, Kurth C. Quantification of changes in electroencephalographic power spectra in a patient with Budd-Chiari-syndrome after implantation of a transjugular intrahepatic portosystemic stent shunt (TIPSS). Metab Brain Dis. 2005;20:1-6. [PMID: 15918545 DOI: 10.1007/s11011-005-2471-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Iwasa M, Matsumura K, Nakagawa Y, Yamamoto M, Tanaka H, Horiike S, Ikoma J, Kaito M, Takeda K, Adachi Y. Evaluation of Cingulate Gyrus Blood Flow in Patients With Liver Cirrhosis. Metab Brain Dis 2005;20:7-17. [DOI: 10.1007/s11011-005-2472-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
48 Zhou Y, Chen S, Jiang L, Guo C, Shen Z, Huang P, Wang J. Development and evaluation of the quality of life instrument in chronic liver disease patients with minimal hepatic encephalopathy. Journal of Gastroenterology and Hepatology 2009;24:408-15. [DOI: 10.1111/j.1440-1746.2008.05678.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
49 Timmermann L, Butz M, Gross J, Kircheis G, Häussinger D, Schnitzler A. Neural Synchronization in Hepatic Encephalopathy. Metab Brain Dis 2005;20:337-46. [DOI: 10.1007/s11011-005-7916-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
50 Weissenborn K, Heidenreich S, Ennen J, Rückert N, Hecker H. Attention deficits in minimal hepatic encephalopathy. Metab Brain Dis. 2001;16:13-19. [PMID: 11726083 DOI: 10.1023/a:1011654210096] [Cited by in Crossref: 79] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
51 Lee JH, Seo DW, Lee Y, Kim S, Mun C, Lim T, Min YI, Suh D. Proton Magnetic Resonance Spectroscopy (1H-Mrs) Findings for The Brain in Patients With Liver Cirrhosis Reflect The Hepatic Functional Reserve. American Journal of Gastroenterology 1999;94:2206-13. [DOI: 10.1111/j.1572-0241.1999.01228.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 1.5] [Reference Citation Analysis]
52 Amodio P, Marchetti P, Del Piccolo F, Rizzo C, Iemmolo RM, Caregaro L, Gerunda G, Gatta A. Study on the Sternberg paradigm in cirrhotic patients without overt hepatic encephalopathy. Metab Brain Dis 1998;13:159-72. [PMID: 9699923 DOI: 10.1023/a:1020665431411] [Cited by in Crossref: 42] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
53 Lockwood AH. Hepatic Encephalopathy. Neurologic Clinics 2002;20:241-6. [DOI: 10.1016/s0733-8619(03)00061-6] [Cited by in Crossref: 6] [Article Influence: 0.3] [Reference Citation Analysis]
54 Velissaris D, Karanikolas M, Kalogeropoulos A, Solomou E, Polychronopoulos P, Thomopoulos K, Labropoulou-Karatza C. Pituitary hormone circadian rhythm alterations in cirrhosis patients with subclinical hepatic encephalopathy. World J Gastroenterol 2008; 14(26): 4190-4195 [PMID: 18636665 DOI: 10.3748/wjg.14.4190] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
55 Kharbanda PS, Prabhakar S. Subclinical hepatic encephalopathy: Elusive ‘gold standard’. Journal of Gastroenterology and Hepatology 2004;19:1-3. [DOI: 10.1111/j.1440-1746.2004.03290.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
56 Moon J, Jun DW, Yum M, Lee KN, Lee HL, Lee OY, Yoon BC, Choi HS, Hahm JS, Seol IJ, Oh J, Kim C. Prolonged N200 is the early neurophysiologic change in the patient with minimal hepatic encephalopathy. Scandinavian Journal of Gastroenterology 2014;49:604-10. [DOI: 10.3109/00365521.2013.878382] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
57 Citro V, Milan G, Tripodi FS, Gennari A, Sorrentino P, Gallotta G, Postiglione A, Tarantino G. Mental status impairment in patients with West Haven grade zero hepatic encephalopathy: the role of HCV infection. J Gastroenterol 2007;42:79-82. [PMID: 17322997 DOI: 10.1007/s00535-006-1978-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
58 Marchetti P, D'Avanzo C, Orsato R, Montagnese S, Schiff S, Kaplan PW, Piccione F, Merkel C, Gatta A, Sparacino G. Electroencephalography in patients with cirrhosis. Gastroenterology. 2011;141:1680-1689.e1-2. [PMID: 21763244 DOI: 10.1053/j.gastro.2011.06.085] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
59 Sugimoto R, Iwasa M, Maeda M, Urawa N, Tanaka H, Fujita N, Kobayashi Y, Takeda K, Kaito M, Takei Y. Value of the apparent diffusion coefficient for quantification of low-grade hepatic encephalopathy. Am J Gastroenterol. 2008;103:1413-1420. [PMID: 18510613 DOI: 10.1111/j.1572-0241.2008.01788.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 2.9] [Reference Citation Analysis]
60 Ott P, Vilstrup H. Cerebral effects of ammonia in liver disease: current hypotheses. Metab Brain Dis. 2014; Feb 4. [Epub ahead of print]. [PMID: 24488230 DOI: 10.1007/s11011-014-9494-7] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 7.3] [Reference Citation Analysis]
61 Amodio P, Campagna F, Olianas S, Iannizzi P, Mapelli D, Penzo M, Angeli P, Gatta A. Detection of minimal hepatic encephalopathy: normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study. J Hepatol. 2008;49:346-353. [PMID: 18602716 DOI: 10.1016/j.jhep.2008.04.022] [Cited by in Crossref: 126] [Cited by in F6Publishing: 113] [Article Influence: 9.0] [Reference Citation Analysis]
62 Mallet M, Weiss N, Thabut D, Rudler M. Why and when to measure ammonemia in cirrhosis? Clin Res Hepatol Gastroenterol 2018;42:505-11. [PMID: 29551609 DOI: 10.1016/j.clinre.2018.01.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
63 Weissenborn K. Challenges in diagnosing hepatic encephalopathy. Neurochem Res 2015;40:265-73. [PMID: 25142937 DOI: 10.1007/s11064-014-1416-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
64 Reeves RR, Struve FA, Burke RS. Quantitative EEG Analysis before and after Liver Transplantation. Clin EEG Neurosci 2006;37:34-40. [DOI: 10.1177/155005940603700108] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
65 Dhiman RK, Saraswat VA, Sharma BK, Sarin SK, Chawla YK, Butterworth R, Duseja A, Aggarwal R, Amarapurkar D, Sharma P, Madan K, Shah S, Seth AK, Gupta RK, Koshy A, Rai RR, Dilawari JB, Mishra SP, Acharya SK. Minimal hepatic encephalopathy: Consensus statement of a working party of the Indian National Association for Study of the Liver: Minimal hepatic encephalopathy. Journal of Gastroenterology and Hepatology 2010;25:1029-41. [DOI: 10.1111/j.1440-1746.2010.06318.x] [Cited by in Crossref: 80] [Cited by in F6Publishing: 70] [Article Influence: 6.7] [Reference Citation Analysis]
66 Román E, Córdoba J, Torrens M, Torras X, Villanueva C, Vargas V, Guarner C, Soriano G. Minimal Hepatic Encephalopathy Is Associated With Falls. American Journal of Gastroenterology 2011;106:476-82. [DOI: 10.1038/ajg.2010.413] [Cited by in Crossref: 120] [Cited by in F6Publishing: 111] [Article Influence: 10.9] [Reference Citation Analysis]
67 Adrover R, Cocozzella D, Ridruejo E, García A, Rome J, Podestá JJ. Breath-ammonia testing of healthy subjects and patients with cirrhosis. Dig Dis Sci. 2012;57:189-195. [PMID: 21842240 DOI: 10.1007/s10620-011-1858-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
68 Amodio P, Pellegrini A, Ubiali E, Mathy I, Piccolo FD, Orsato R, Gatta A, Guerit J. The EEG assessment of low-grade hepatic encephalopathy: Comparison of an artificial neural network-expert system (ANNES) based evaluation with visual EEG readings and EEG spectral analysis. Clinical Neurophysiology 2006;117:2243-51. [DOI: 10.1016/j.clinph.2006.06.714] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
69 Giger-Mateeva VI, Reits D, Liberov B, Jones EA, Spekreijse H. The effect of flumazenil on visual event-related potentials of clinically non-encephalopathic patients with cirrhosis. Neurosci Lett 1999;276:173-6. [PMID: 10612633 DOI: 10.1016/s0304-3940(99)00817-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
70 Lockwood AH. Early detection and treatment of hepatic encephalopathy. Curr Opin Neurol. 1998;11:663-666. [PMID: 9870134 DOI: 10.1097/00019052-199812000-00009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
71 Luo M, Li L, Lu CZ, Cao WK. Clinical efficacy and safety of lactulose for minimal hepatic encephalopathy: a meta-analysis. Eur J Gastroenterol Hepatol. 2011;23:1250-1257. [PMID: 21971378 DOI: 10.1097/meg.0b013e32834d1938] [Cited by in Crossref: 43] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
72 Weissenborn K, Rückert N, Hecker H, Manns MP. The number connection tests A and B: interindividual variability and use for the assessment of early hepatic encephalopathy. J Hepatol 1998;28:646-53. [PMID: 9566834 DOI: 10.1016/s0168-8278(98)80289-4] [Cited by in Crossref: 84] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
73 Amodio P, Wenin H, Del Piccolo F, Mapelli D, Montagnese S, Pellegrini A, Musto C, Gatta A, Umiltà C. Variability of trail making test, symbol digit test and line trait test in normal people. A normative study taking into account age-dependent decline and sociobiological variables. Aging Clin Exp Res 2002;14:117-31. [PMID: 12092785 DOI: 10.1007/BF03324425] [Cited by in Crossref: 99] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
74 Guerit JM, Amantini A, Fischer C, Kaplan PW, Mecarelli O, Schnitzler A, Ubiali E, Amodio P; members of the ISHEN commission on Neurophysiological Investigations. Neurophysiological investigations of hepatic encephalopathy: ISHEN practice guidelines. Liver Int. 2009;29:789-796. [PMID: 19638107 DOI: 10.1111/j.1478-3231.2009.02030.x] [Cited by in Crossref: 94] [Cited by in F6Publishing: 78] [Article Influence: 7.2] [Reference Citation Analysis]
75 Amodio P, Del Piccolo F, Marchetti P, Angeli P, Iemmolo R, Caregaro L, Merkel C, Gerunda G, Gatta A. Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests. Hepatology. 1999;29:1662-1667. [PMID: 10347105 DOI: 10.1002/hep.510290619] [Cited by in Crossref: 175] [Cited by in F6Publishing: 160] [Article Influence: 7.6] [Reference Citation Analysis]
76 Romero-Gómez M, Boza F, García-Valdecasas MS, García E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol. 2001;96:2718-2723. [PMID: 11569701 DOI: 10.1111/j.1572-0241.2001.04130.x] [Cited by in Crossref: 233] [Cited by in F6Publishing: 221] [Article Influence: 11.1] [Reference Citation Analysis]
77 Malaguarnera M, Gargante MP, Cristaldi E, Vacante M, Risino C, Cammalleri L, Pennisi G, Rampello L. Acetyl-L-carnitine treatment in minimal hepatic encephalopathy. Dig Dis Sci. 2008;53:3018-3025. [PMID: 18357530 DOI: 10.1007/s10620-008-0238-6] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 4.4] [Reference Citation Analysis]
78 Amodio P, Marchetti P, Del Piccolo F, Campo G, Rizzo C, Iemmolo RM, Gerunda G, Caregaro L, Merkel C, Gatta A. Visual attention in cirrhotic patients: a study on covert visual attention orienting. Hepatology. 1998;27:1517-1523. [PMID: 9620321 DOI: 10.1002/hep.510270608] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 1.8] [Reference Citation Analysis]
79 Riggio O, Ridola L, Pasquale C, Nardelli S, Pentassuglio I, Moscucci F, Merli M. Evidence of Persistent Cognitive Impairment After Resolution of Overt Hepatic Encephalopathy. Clinical Gastroenterology and Hepatology 2011;9:181-3. [DOI: 10.1016/j.cgh.2010.10.002] [Cited by in Crossref: 71] [Cited by in F6Publishing: 70] [Article Influence: 6.5] [Reference Citation Analysis]
80 Kato A, Tanaka H, Kawaguchi T, Kanazawa H, Iwasa M, Sakaida I, Moriwaki H, Murawaki Y, Suzuki K, Okita K. Nutritional management contributes to improvement in minimal hepatic encephalopathy and quality of life in patients with liver cirrhosis: A preliminary, prospective, open-label study. Hepatol Res. 2013;43:452-458. [PMID: 22994429 DOI: 10.1111/j.1872-034x.2012.01092.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
81 Velissaris D, Karamouzos V, Polychronopoulos P, Karanikolas M. Chronotypology and melatonin alterations in minimal hepatic encephalopathy. J Circadian Rhythms 2009;7:6. [PMID: 19480668 DOI: 10.1186/1740-3391-7-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
82 Rössle M, Euringer W. Hepatic Encephalopathy in Patients with Transjugular Intrahepatic Portosystemic Shunt (TIPS). In: Mullen KD, Prakash RK, editors. Hepatic Encephalopathy. Totowa: Humana Press; 2012. pp. 211-20. [DOI: 10.1007/978-1-61779-836-8_17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
83 Montagnese S, Jackson C, Morgan MY. Spatio-temporal decomposition of the electroencephalogram in patients with cirrhosis. Journal of Hepatology 2007;46:447-58. [DOI: 10.1016/j.jhep.2006.10.015] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 4.1] [Reference Citation Analysis]
84 Routhu M, Safka V, Routhu SK, Fejfar T, Jirkovsky V, Krajina A, Cermakova E, Hosak L, Hulek P. Observational cohort study of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS). Ann Hepatol. 2017;16:140-148. [PMID: 28051803 DOI: 10.5604/16652681.1226932] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
85 Li T, Li X, Zhou W, Cui X, Ma L. Dynamic susceptibility contrast-enhanced first-pass perfusion MR imaging in patients with subclinical hepatic encephalopathy. J Neuroradiol. 2012;39:290-294. [PMID: 22047891 DOI: 10.1016/j.neurad.2011.09.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
86 Cordoba J. Hepatic Encephalopathy: From the Pathogenesis to the New Treatments. ISRN Hepatol 2014;2014:236268. [PMID: 27335836 DOI: 10.1155/2014/236268] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
87 Wang JY, Zhang NP, Chi BR, Mi YQ, Meng LN, Liu YD, Wang JB, Jiang HX, Yang JH, Xu Y, Li X, Xu JM, Zhang G, Zhou XM, Zhuge YZ, Tian DA, Ye J, Liu YL. Prevalence of minimal hepatic encephalopathy and quality of life evaluations in hospitalized cirrhotic patients in China. World J Gastroenterol 2013; 19(30): 4984-4991 [PMID: 23946605 DOI: 10.3748/wjg.v19.i30.4984] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
88 Sunil HV, Mittal BR, Kurmi R, Chawla YK, Dhiman RK. Brain perfusion single photon emission computed tomography abnormalities in patients with minimal hepatic encephalopathy. J Clin Exp Hepatol 2012;2:116-21. [PMID: 25755420 DOI: 10.1016/S0973-6883(12)60099-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
89 Valenti P, Ortelli P, Zanon A, Schiff S, Montagnese S, Avruscio G, Del Piccolo F, Mapelli D, Puato M, Rattazzi M, Amodio P, Pauletto P. Psychometric and EEG changes after carotid endarterectomy. Metab Brain Dis 2015;30:99-105. [PMID: 25034456 DOI: 10.1007/s11011-014-9589-1] [Reference Citation Analysis]
90 Blauenfeldt RA, Olesen SS, Hansen JB, Graversen C, Drewes AM. Abnormal brain processing in hepatic encephalopathy: evidence of cerebral reorganization? Eur J Gastroenterol Hepatol 2010;22:1323-30. [PMID: 20661140 DOI: 10.1097/MEG.0b013e32833d4717] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
91 Hilgier W, Zielińska M, Borkowska H, Gadamski R, Walski M, Oja S, Saransaari P, Albrecht J. Changes in the extracellular profiles of neuroactive amino acids in the rat striatum at the asymptomatic stage of hepatic failure. J Neurosci Res 1999;56:76-84. [DOI: 10.1002/(sici)1097-4547(19990401)56:1<76::aid-jnr10>3.0.co;2-y] [Cited by in Crossref: 49] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
92 Amodio P, Del Piccolo F, Pettenò E, Mapelli D, Angeli P, Iemmolo R, Muraca M, Musto C, Gerunda G, Rizzo C, Merkel C, Gatta A. Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients. Journal of Hepatology 2001;35:37-45. [DOI: 10.1016/s0168-8278(01)00129-5] [Cited by in Crossref: 167] [Cited by in F6Publishing: 44] [Article Influence: 8.0] [Reference Citation Analysis]
93 Jones EA, Giger-Mateeva VI, Reits D, Riemslag FC, Liberov B, Spekrijse H. Visual event-related potentials in cirrhotic patients without overt encephalopathy: the effects of flumazenil. Metab Brain Dis 2001;16:43-53. [PMID: 11726088 DOI: 10.1023/a:1011662411913] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
94 Montagnese S, Amodio P, Morgan MY. Methods for Diagnosing Hepatic Encephalopathy in Patients with Cirrhosis: A Multidimensional Approach. Metab Brain Dis 2004;19:281-312. [DOI: 10.1023/b:mebr.0000043977.11113.2a] [Cited by in Crossref: 83] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
95 Wunsch E, Koziarska D, Kotarska K, Nowacki P, Milkiewicz P. Normalization of the psychometric hepatic encephalopathy score in Polish population. A prospective, quantified electroencephalography study. Liver Int 2013;33:1332-40. [DOI: 10.1111/liv.12194] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
96 Kircheis G, Bode JG, Hilger N, Kramer T, Schnitzler A, Häussinger D. Diagnostic and prognostic values of critical flicker frequency determination as new diagnostic tool for objective HE evaluation in patients undergoing TIPS implantation. Eur J Gastroenterol Hepatol. 2009;21:1383-1394. [PMID: 19738480 DOI: 10.1097/MEG.0b013e328310e0c3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
97 Randolph C, Hilsabeck R, Kato A, Kharbanda P, Li YY, Mapelli D, Ravdin LD, Romero-Gomez M, Stracciari A, Weissenborn K; International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN). Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines. Liver Int. 2009;29:629-635. [PMID: 19302444 DOI: 10.1111/j.1478-3231.2009.02009.x] [Cited by in Crossref: 150] [Cited by in F6Publishing: 123] [Article Influence: 11.5] [Reference Citation Analysis]
98 Sharma P, Sharma BC, Puri V, Sarin SK. Minimal Hepatic Encephalopathy in Patients With Extrahepatic Portal Vein Obstruction. Am J Gastroenterology 2008;103:1406-12. [DOI: 10.1111/j.1572-0241.2008.01830.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
99 Scotiniotis IA, Lucey MR, Metz DC. Helicobacter pylori infection is not associated with subclinical hepatic encephalopathy in stable cirrhotic patients. Dig Dis Sci. 2001;46:2744-2751. [PMID: 11768268 DOI: 10.1023/a:1012787731821] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
100 Groeneweg M, Quero JC, De Bruijn I, Hartmann IJ, Essink-bot M, Hop WC, Schalm SW. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 1998;28:45-9. [DOI: 10.1002/hep.510280108] [Cited by in Crossref: 363] [Cited by in F6Publishing: 327] [Article Influence: 15.1] [Reference Citation Analysis]
101 Soriano G, Román E, Córdoba J, Torrens M, Poca M, Torras X, Villanueva C, Gich IJ, Vargas V, Guarner C. Cognitive dysfunction in cirrhosis is associated with falls: a prospective study. Hepatology 2012;55:1922-30. [PMID: 22213000 DOI: 10.1002/hep.25554] [Cited by in Crossref: 68] [Cited by in F6Publishing: 59] [Article Influence: 6.8] [Reference Citation Analysis]
102 Ciancio A, Marchet A, Saracco G, Carucci P, Lavezzo B, Leotta D, Capellero B, Nobili M, Smedile A, Rizzetto M. Spectral electroencephalogram analysis in hepatic encephalopathy and liver transplantation. Liver Transpl 2002;8:630-5. [PMID: 12089718 DOI: 10.1053/jlts.2002.33971] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.2] [Reference Citation Analysis]
103 Fiati Kenston SS, Song X, Li Z, Zhao J. Mechanistic insight, diagnosis, and treatment of ammonia-induced hepatic encephalopathy. J Gastroenterol Hepatol. 2019;34:31-39. [PMID: 30070387 DOI: 10.1111/jgh.14408] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
104 Ortiz M, Jacas C, Córdoba J. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. Journal of Hepatology 2005;42:S45-53. [DOI: 10.1016/j.jhep.2004.11.028] [Cited by in Crossref: 178] [Cited by in F6Publishing: 166] [Article Influence: 10.5] [Reference Citation Analysis]
105 El-Karaksy HM, Afifi O, Bakry A, Kader AA, Saber N. A pilot study using lactulose in management of minimal hepatic encephalopathy in children with extrahepatic portal vein obstruction. World J Pediatr 2017;13:70-5. [PMID: 27878780 DOI: 10.1007/s12519-016-0066-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
106 Duarte-Rojo A, Ruiz-Margáin A, Macias-Rodriguez RU, Cubero FJ, Estradas-Trujillo J, Muñoz-Fuentes RM, Torre A. Clinical scenarios for the use of S100β as a marker of hepatic encephalopathy. World J Gastroenterol 2016; 22(17): 4397-4402 [PMID: 27158209 DOI: 10.3748/wjg.v22.i17.4397] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
107 Özbaş B, Keskin O, Hecker H, Karahan I, Özbaş C, Kalkan Ç, Kartal A, Önder FO, Öncü BK, Gençdal G, Akyildiz M, Günşar F, Idilman R, Weissenborn K, Özütemiz Ö, Yurdaydin C. Determination of Turkish norms of psychometric tests for diagnosing minimal hepatic encephalopathy and proposal of a high sensitive screening test battery. Hepatol Int 2021. [PMID: 34085147 DOI: 10.1007/s12072-021-10207-5] [Reference Citation Analysis]
108 Arango-Lasprilla JC, Rivera D, Rodríguez G, Garza MT, Galarza-Del-Angel J, Rodríguez W, Velázquez-Cardoso J, Aguayo A, Schebela S, Weil C, Longoni M, Aliaga A, Ocampo-Barba N, Saracho CP, Panyavin I, Esenarro L, Martínez C, García de la Cadena C, Perrin PB. Symbol Digit Modalities Test: Normative data for the Latin American Spanish speaking adult population. NeuroRehabilitation 2015;37:625-38. [PMID: 26639927 DOI: 10.3233/NRE-151282] [Cited by in Crossref: 22] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
109 Weissenborn K. Portosystemic encephalopathy. Neurologic Aspects of Systemic Disease Part II. Elsevier; 2014. pp. 661-74. [DOI: 10.1016/b978-0-7020-4087-0.00045-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
110 Vásconez C, Elizalde JI, Llach J, Ginès A, de la Rosa C, Fernández RM, Mas A, Santamaría J, Bordas JM, Piqué JM, Terés J. Helicobacter pylori, hyperammonemia and subclinical portosystemic encephalopathy: effects of eradication. J Hepatol 1999;30:260-4. [PMID: 10068106 DOI: 10.1016/s0168-8278(99)80072-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
111 Rudler M, Weiss N, Bouzbib C, Thabut D. Diagnosis and Management of Hepatic Encephalopathy. Clin Liver Dis 2021;25:393-417. [PMID: 33838857 DOI: 10.1016/j.cld.2021.01.008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
112 Montagnese S, De Rui M, Angeli P, Amodio P. Neuropsychiatric performance in patients with cirrhosis: Who is "normal"? J Hepatol 2017;66:825-35. [PMID: 27923694 DOI: 10.1016/j.jhep.2016.11.021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
113 Liao LM, Zhou LX, Le HB, Yin JJ, Ma SH. Spatial working memory dysfunction in minimal hepatic encephalopathy: an ethology and BOLD-fMRI study.Brain Res. 2012;1445:62-72. [PMID: 22325099 DOI: 10.1016/j.brainres.2012.01.036] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
114 Amodio P, Caregaro L, Pattenò E, Marcon M, Del Piccolo F, Gatta A. Vegetarian diets in hepatic encephalopathy: facts or fantasies? Dig Liver Dis 2001;33:492-500. [PMID: 11572577 DOI: 10.1016/s1590-8658(01)80028-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
115 Kahn E. Biliary Atresia Revisited. Pediatr Dev Pathol 2004;7:109-24. [DOI: 10.1007/s10024-003-0307-y] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 16.0] [Reference Citation Analysis]
116 Morgan MY, Amodio P, Cook NA, Jackson CD, Kircheis G, Lauridsen MM, Montagnese S, Schiff S, Weissenborn K. Qualifying and quantifying minimal hepatic encephalopathy. Metab Brain Dis 2016;31:1217-29. [PMID: 26412229 DOI: 10.1007/s11011-015-9726-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
117 Mardini HA, Douglass A, Record C. Amino Acid Challenge in Patients with Cirrhosis and Control Subjects: Ammonia, Plasma Amino Acid and EEG Changes. Metab Brain Dis 2006;21:1-10. [DOI: 10.1007/s11011-006-9006-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
118 Kircheis G, Görtelmeyer R, Fleig WE, Häussinger D. Critical assessment of the PHES test battery in patients with low-grade hepatic encephalopathy. In: Häussinger D, Kircheis G, Schliess F, editors. Hepatic Encephalopathy and Nitrogen Metabolism. Dordrecht: Springer Netherlands; 2006. pp. 495-502. [DOI: 10.1007/1-4020-4456-9_39] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
119 Nardone R, Taylor AC, Höller Y, Brigo F, Lochner P, Trinka E. Minimal hepatic encephalopathy: A review. Neurosci Res 2016;111:1-12. [PMID: 27153746 DOI: 10.1016/j.neures.2016.04.009] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 5.5] [Reference Citation Analysis]
120 Amorós A, Aparicio JR, Garmendia M, Casellas JA, Martínez J, Jover R. Deep sedation with propofol does not precipitate hepatic encephalopathy during elective upper endoscopy. Gastrointest Endosc. 2009;70:262-268. [PMID: 19394004 DOI: 10.1016/j.gie.2008.10.038] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
121 Jayakumar AR, Norenberg MD. Hyperammonemia in Hepatic Encephalopathy. J Clin Exp Hepatol. 2018;8:272-280. [PMID: 30302044 DOI: 10.1016/j.jceh.2018.06.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
122 Thuluvath PJ, Nuthalapati A, Price J, Maheshwari A. Driving Performance Among Patients with Cirrhosis Who Drove to Their Outpatient Hepatology Clinic Appointments. J Clin Exp Hepatol 2016;6:3-9. [PMID: 27194889 DOI: 10.1016/j.jceh.2015.09.003] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
123 Amodio P, Gatta A. Neurophysiological Investigation of Hepatic Encephalopathy. Metab Brain Dis 2005;20:369-79. [DOI: 10.1007/s11011-005-7921-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
124 Amodio P, Marchetti P, Del Piccolo F, Rizzo C, Iemmolo RM, Caregaro L, Gerunda G, Gatta A. Study on the Sternberg paradigm in cirrhotic patients without overt hepatic encephalopathy. Metab Brain Dis. 1998;13:159-172. [PMID: 9699923 DOI: 10.1023/a: 1020665431411] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
125 Bianchi G, Giovagnoli M, Sasdelli AS, Marchesini G. Hepatic encephalopathy and health-related quality of life. Clin Liver Dis 2012;16:159-70. [PMID: 22321471 DOI: 10.1016/j.cld.2011.12.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
126 Akhtar AJ, Alamy ME, Yoshikawa TT. Extrahepatic conditions and hepatic encephalopathy in elderly patients. Am J Med Sci 2002;324:1-4. [PMID: 12120819 DOI: 10.1097/00000441-200207000-00001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
127 Kappus MR, Bajaj JS. Assessment of minimal hepatic encephalopathy (with emphasis on computerized psychometric tests). Clin Liver Dis. 2012;16:43-55. [PMID: 22321464 DOI: 10.1016/j.cld.2011.12.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
128 Amodio P, Montagnese S, Gatta A, Morgan MY. Characteristics of Minimal Hepatic Encephalopathy. Metab Brain Dis 2004;19:253-67. [DOI: 10.1023/b:mebr.0000043975.01841.de] [Cited by in Crossref: 196] [Cited by in F6Publishing: 76] [Article Influence: 10.9] [Reference Citation Analysis]
129 Pellegrini A, Ubiali E, Orsato R, Schiff S, Gatta A, Castellaro A, Casagrande A, Amodio P. Electroencephalographic staging of hepatic encephalopathy by an artificial neural network and an expert system. Neurophysiol Clin. 2005;35:162-167. [PMID: 16530133 DOI: 10.1016/j.neucli.2005.12.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
130 Schiff S, Mapelli D, Vallesi A, Orsato R, Gatta A, Umiltà C, Amodio P. Top-down and bottom-up processes in the extrastriate cortex of cirrhotic patients: An ERP study. Clinical Neurophysiology 2006;117:1728-36. [DOI: 10.1016/j.clinph.2006.04.020] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]